Abstract 142
Author:
Goutham N Vemuri, goutham.vemuri@bio-amber.com
Biocatalysis Development, BioAmber, Plymouth, Minnesota 55447, United States
Bio-based succinic acid has emerged to be the C4-platform of interest for the production of renewable chemicals, with applications in food, pharmaceutical and cosmetics.
The benign environmental profile, superior economics and the novel performance of bio-based succinic acid in comparison to petroleum-derived succinic acid propel the development of biological processes for the production of succinate and its derivatives.
At BioAmber, we are already at the forefront in testing and developing bio-based succinic acid in a variety of applications ranging from polyurethanes, resins, coatings, phthalate-free plasticizers, deicing salts, cosmetics, flavors and fragrances.
In all these applications, bio-based succinic acid offered a unique combination of performance, economic and environmental benefits.
We are the first in the market with commercial scale production of bio-based succinic acid, and are currently serving customers from our plant in Europe. This plant has been audited and qualified for commercial manufacturing. As a consequence of the market demand, our present capacity increased from 2,000 MT/year to 3,000 MT/year.
Additionally, we are also advancing new product platform based on modified polybutylene succinate (mPBS). Through a joint venture with NatureWorks, the leader in bio-plastics, a new family of bio-based polymers blended with mPBS and PLA is available.
We have taken advantage of our foundation in the C4 platform to expand our product portfolio to C6 chemicals, notably, adipic acid, bio-caprolactam and bio-hexamethylenediamine. Our proprietary technology platform integrates industrial biotechnology, a novel purification scheme and chemical catalysis to convert renewable feedstocks into value-added chemicals for use in a wide variety of everyday products.
Goutham N Vemuri, goutham.vemuri@bio-amber.com
Biocatalysis Development, BioAmber, Plymouth, Minnesota 55447, United States
Bio-based succinic acid has emerged to be the C4-platform of interest for the production of renewable chemicals, with applications in food, pharmaceutical and cosmetics.
The benign environmental profile, superior economics and the novel performance of bio-based succinic acid in comparison to petroleum-derived succinic acid propel the development of biological processes for the production of succinate and its derivatives.
At BioAmber, we are already at the forefront in testing and developing bio-based succinic acid in a variety of applications ranging from polyurethanes, resins, coatings, phthalate-free plasticizers, deicing salts, cosmetics, flavors and fragrances.
In all these applications, bio-based succinic acid offered a unique combination of performance, economic and environmental benefits.
We are the first in the market with commercial scale production of bio-based succinic acid, and are currently serving customers from our plant in Europe. This plant has been audited and qualified for commercial manufacturing. As a consequence of the market demand, our present capacity increased from 2,000 MT/year to 3,000 MT/year.
Additionally, we are also advancing new product platform based on modified polybutylene succinate (mPBS). Through a joint venture with NatureWorks, the leader in bio-plastics, a new family of bio-based polymers blended with mPBS and PLA is available.
We have taken advantage of our foundation in the C4 platform to expand our product portfolio to C6 chemicals, notably, adipic acid, bio-caprolactam and bio-hexamethylenediamine. Our proprietary technology platform integrates industrial biotechnology, a novel purification scheme and chemical catalysis to convert renewable feedstocks into value-added chemicals for use in a wide variety of everyday products.
